Skip to main content

UBS Group AG

Position in GLUE — Monte Rosa Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in GLUE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,860,158
+$2,349,560 QoQ
Shares Held
200,833
+31.6% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 193 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in GLUE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. GLUE ranks #148 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GLUE

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,860,158 200,833
2026-03-31 $2,510,598 152,620
2025-12-31 $1,928,639 123,000
2025-09-30 $534,223 72,095
2025-06-30 $488,166 108,241
2025-03-31 $424,624 91,514
2024-12-31 $412,228 59,399
2024-09-30 $134,264 25,333
2024-06-30 $87,119 23,294
2024-03-31 $290,269 41,173
2023-12-31 $214,406 37,948
2023-09-30 $111,650 23,309
2023-06-30 $162,858 23,775
2023-03-31 $81,062 10,406
2022-12-31 $70,369 9,247
2022-03-31 $412,300 29,408
2021-12-31 $66,569 3,260